Physician profile
Tony Chu
NPI 1851370092
$11,823.58
in general payments reported to CMS, 2019-2025
40 companies · $1,615 in 2025
The $1,615 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,167 · 2020: $1,166 · 2021: $2,342 · 2022: $1,575 · 2023: $2,015 · 2024: $1,943 · 2025: $1,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,572.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,925.95 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,589.42 | 2019-2025 | |
| Abbott Laboratories | $1,067.31 | 2019-2025 | Mitraclip, Diamondback Peripheral, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $1,053.41 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $744.48 | 2020-2025 | Brilinta, Farxiga, Lynparza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $667.90 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $572.79 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $550.54 | 2019-2025 | |
| Amgen INC. | $473.76 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $334.20 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $326.91 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $326.64 | 2021-2025 | Verquvo |
| Cvrx, INC. | $320.11 | 2022-2025 | Barostim Neo System |
| Medtronic, INC. | $195.46 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra |
| W. L. Gore & Associates, INC. | $192.91 | 2020-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $190.19 | 2020-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $184.58 | 2024-2025 | Amvuttra, Onpattro |
| Amarin Pharma, INC. | $156.37 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $104.65 | 2024 | Arcalyst |
| Boston Scientific Corporation | $95.70 | 2019-2025 | Watchman Flx, Watchman Access System |
| Abiomed | $84.52 | 2024 | Impella |
| Kiniksa Pharmaceuticals, LTD. | $73.40 | 2021-2023 | Arcalyst |
| Heartflow, INC. | $73.07 | 2024 | |
| Bridgebio Pharma, INC. | $63.26 | 2025 | Attruby |
| Tactile Systems Technology INC | $57.90 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Actelion Pharmaceuticals US, INC. | $47.37 | 2023-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $42.06 | 2021-2022 | |
| Edwards Lifesciences Corporation | $38.88 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biosense Webster, INC. | $34.46 | 2019 | |
| Kestra Medical Technology Services, INC. | $33.85 | 2024-2025 | Assure Wcd |
| Biotronik INC. | $32.59 | 2025 | Biomonitor |
| Lexicon Pharmaceuticals, INC. | $29.78 | 2023-2024 | Inpefa |
| Cardiovascular Systems INC. | $25.66 | 2022 | |
| Atricure, INC. | $25.17 | 2024 | |
| Potrero Medical, INC. | $17.12 | 2023 | |
| Imperative Care, INC | $16.97 | 2025 | Symphony Catheter |
| Regeneron Healthcare Solutions, INC. | $14.81 | 2019 | |
| Esperion Therapeutics, INC. | $13.84 | 2021 | |
| Medicure Pharma INC. | $13.65 | 2021 | |
| Medtronic Vascular, INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tony Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.